Gary E. Brandt

Person

Alameda, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 12,172,994
- Issue date Dec 24, 2024
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopressin receptor antagonists and products and methods related t...
- Patent number 12,152,038
- Issue date Nov 26, 2024
- NEUMORA THERAPEUTICS, INC.
- Robert M. Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 11,878,977
- Issue date Jan 23, 2024
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopressin receptor antagonists and products and methods related t...
- Patent number 11,858,943
- Issue date Jan 2, 2024
- NEUMORA THERAPEUTICS, INC.
- Robert M. Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 11,667,637
- Issue date Jun 6, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 11,453,668
- Issue date Sep 27, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 11,420,965
- Issue date Aug 23, 2022
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,299,492
- Issue date Apr 12, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 11,254,669
- Issue date Feb 22, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopressin receptor antagonists and products and methods related t...
- Patent number 11,186,577
- Issue date Nov 30, 2021
- BlackThorn Therapeutics, Inc.
- Robert M. Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 10,988,470
- Issue date Apr 27, 2021
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,954,237
- Issue date Mar 23, 2021
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,913,740
- Issue date Feb 9, 2021
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 10,562,894
- Issue date Feb 18, 2020
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,550,118
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vasopressin receptor antagonists and products and methods related t...
- Patent number 10,538,530
- Issue date Jan 21, 2020
- BlackThorn Therapeutics, Inc.
- Robert M. Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,526,330
- Issue date Jan 7, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 10,519,153
- Issue date Dec 31, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,392,386
- Issue date Aug 27, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 10,308,646
- Issue date Jun 4, 2019
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 10,208,040
- Issue date Feb 19, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,196,393
- Issue date Feb 5, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,100,049
- Issue date Oct 16, 2018
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridines as JAK kinase inhibitors
- Patent number 9,725,470
- Issue date Aug 8, 2017
- Theravance Biopharma R&D IP, LLC
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-pr...
- Patent number 9,193,719
- Issue date Nov 24, 2015
- Deciphera Pharmaceuticals, LLC
- Daniel L. Flynn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20240158389
- Publication date May 16, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20240132520
- Publication date Apr 25, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...
- Publication number 20230093235
- Publication date Mar 23, 2023
- BlackThorn Therapeutics, Inc.
- Robert M. Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-(2,6-DIAZASPIRO[3.3]HEPTAN-6-YL)-5,6-DIHYDRO-4H-BENZO[F][1,2,4]TR...
- Publication number 20230084719
- Publication date Mar 16, 2023
- BlackThorn Therapeutics, Inc.
- Gary Brandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20230063643
- Publication date Mar 2, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20220396573
- Publication date Dec 15, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20220289737
- Publication date Sep 15, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...
- Publication number 20210317126
- Publication date Oct 14, 2021
- BlackThorn Therapeutics, Inc.
- Robert M. Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20210269436
- Publication date Sep 2, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20210214349
- Publication date Jul 15, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20210130351
- Publication date May 6, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20200369660
- Publication date Nov 26, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20200216447
- Publication date Jul 9, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20200181141
- Publication date Jun 11, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20200087303
- Publication date Mar 19, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20190337945
- Publication date Nov 7, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20190241555
- Publication date Aug 8, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...
- Publication number 20190169202
- Publication date Jun 6, 2019
- BlackThorn Therapeutics, Inc.
- Robert M. Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20190127371
- Publication date May 2, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20190127364
- Publication date May 2, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20190119275
- Publication date Apr 25, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20190106420
- Publication date Apr 11, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...
- Publication number 20190048013
- Publication date Feb 14, 2019
- BlackThorn Therapeutics, Inc.
- Robert M. Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20180258088
- Publication date Sep 13, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20180258087
- Publication date Sep 13, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20170121327
- Publication date May 4, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20160347772
- Publication date Dec 1, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,2,4-TRIAZOL-5-ONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PR...
- Publication number 20140296252
- Publication date Oct 2, 2014
- Deciphera Pharmaceuticals, LLC
- Daniel L. Flynn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Gary E. Brandt

Person

Patents Grantslast 30 patents

Pyrimidine compound as JAK kinase inhibitor

Vasopressin receptor antagonists and products and methods related t...

JAK inhibitors containing a 4-membered heterocyclic amide

Vasopressin receptor antagonists and products and methods related t...

JAK kinase inhibitor compounds for treatment of respiratory disease

Fused imidazo-piperidine JAK inhibitors

JAK inhibitors containing a 4-membered heterocyclic amide

Pyrimidine compound as JAK kinase inhibitor

JAK kinase inhibitor compounds for treatment of respiratory disease

Fused imidazo-piperidine JAK inhibitors

Vasopressin receptor antagonists and products and methods related t...

Pyrimidine compound as JAK kinase inhibitor

JAK inhibitors containing a 4-membered heterocyclic amide

JAK kinase inhibitor compounds for treatment of respiratory disease

Pyrimidine compound as JAK kinase inhibitor

JAK inhibitors containing a 4-membered heterocyclic amide

Vasopressin receptor antagonists and products and methods related t...

JAK kinase inhibitor compounds for treatment of respiratory disease

Fused imidazo-piperidine JAK inhibitors

JAK inhibitors containing a 4-membered heterocyclic amide

Pyrimidine compound as JAK kinase inhibitor

Fused imidazo-piperidine JAK inhibitors

JAK inhibitors containing a 4-membered heterocyclic amide

JAK kinase inhibitor compounds for treatment of respiratory disease

Substituted naphthyridines as JAK kinase inhibitors

1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-pr...

Patents Applicationslast 30 patents

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...

1-(2,6-DIAZASPIRO[3.3]HEPTAN-6-YL)-5,6-DIHYDRO-4H-BENZO[F][1,2,4]TR...

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED T...

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

1,2,4-TRIAZOL-5-ONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PR...